Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacillary angiomatosis

T G Berger1, J E Koehler

  • 1University of California-San Francisco.

AIDS Clinical Review
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Bacillary angiomatosis (BA) presents with varied skin lesions and organ involvement. Effective treatment with erythromycin is crucial, though lifelong therapy may be needed for HIV-infected patients to prevent relapse.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the proliferation and excretion of Bartonella quintana between body and head lice following oral challenge.

Insect molecular biology·2017
Same author

Isolation of Bartonella henselae, Bartonella koehlerae subsp. koehlerae, Bartonella koehlerae subsp. bothieri and a new subspecies of B. koehlerae from free-ranging lions (Panthera leo) from South Africa, cheetahs (Acinonyx jubatus) from Namibia and captive cheetahs from California.

Epidemiology and infection·2016
Same author

Differential gene expression in laboratory strains of human head and body lice when challenged with Bartonella quintana, a pathogenic bacterium.

Insect molecular biology·2014
Same author

[Disseminated papules in a patient with acute myeloid leukemia].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2010
Same author

Severe exfoliative erythema of malnutrition in a child with coexisting coeliac and Hartnup's disease.

Clinical and experimental dermatology·2008
Same author

A newly identified splice site mutation in ZMPSTE24 causes restrictive dermopathy in the Middle East.

The British journal of dermatology·2008
Same journal

Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy.

AIDS clinical review·2000
Same journal

Rationale for immune-based therapies for human immunodeficiency virus type 1 infection.

AIDS clinical review·2000
Same journal

Drug interactions of antiretroviral agents.

AIDS clinical review·2000
Same journal

Salvage therapy for patients failing their current antiretroviral regimen.

AIDS clinical review·2000
Same journal

Reconstitution of immunity against opportunistic infections in the era of potent antiretroviral therapy.

AIDS clinical review·2000
Same journal

Can immune responses to human immunodeficiency virus be preserved, enhanced, or restored?

AIDS clinical review·2000
See all related articles

Area of Science:

  • Infectious Diseases
  • Dermatology
  • Hepatology

Background:

  • Bacillary angiomatosis (BA) is an opportunistic infection.
  • It manifests with diverse cutaneous and visceral lesions.
  • Caused by Bartonella species (Rochalimaea henselae, R. quintana).

Purpose of the Study:

  • To describe the clinical manifestations of bacillary angiomatosis.
  • To identify causative organisms and their sources.
  • To outline treatment strategies and long-term management.

Main Methods:

  • Case identification and clinical observation.
  • Bacteriological culture from lesions and blood.
  • Review of treatment outcomes and follow-up.

Related Experiment Videos

Main Results:

  • BA presents with skin lesions and affects spleen and liver.
  • Rochalimaea henselae and R. quintana cultured from BA lesions and blood.
  • Erythromycin is the primary treatment for HIV-infected patients.

Conclusions:

  • Early diagnosis and treatment of BA are essential.
  • Erythromycin regimen requires 2-4 months.
  • Lifelong suppressive therapy may be necessary for HIV-positive individuals to prevent recurrence.